<?xml version="1.0" encoding="UTF-8"?>
<p id="Par57">There are also ongoing trials for anti-TNF use in COVID-19 (ChiCTR2000030089, ChiCTR2000030580). A combination of different biologic agents may also be considered in selected, very severe cases.</p>
